These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23676470)

  • 1. Development of a new positron emission tomography tracer for targeting tumor angiogenesis: synthesis, small animal imaging, and radiation dosimetry.
    Patterson C; Frederick CB; Yuan H; Dyer LA; Lockyer P; Lalush DS; Veleva AN
    Molecules; 2013 May; 18(5):5594-610. PubMed ID: 23676470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
    Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
    Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide.
    Nielsen CH; Kimura RH; Withofs N; Tran PT; Miao Z; Cochran JR; Cheng Z; Felsher D; Kjær A; Willmann JK; Gambhir SS
    Cancer Res; 2010 Nov; 70(22):9022-30. PubMed ID: 21062977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography imaging of CD105 expression during tumor angiogenesis.
    Hong H; Yang Y; Zhang Y; Engle JW; Barnhart TE; Nickles RJ; Leigh BR; Cai W
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1335-43. PubMed ID: 21373764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
    Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
    J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin alpha v beta 3-targeted imaging of lung cancer.
    Chen X; Sievers E; Hou Y; Park R; Tohme M; Bart R; Bremner R; Bading JR; Conti PS
    Neoplasia; 2005 Mar; 7(3):271-9. PubMed ID: 15799827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Claron M; Boturyn D; Coll JL; Fukumura T; Fujibayashi Y; Dumy P; Saga T
    Angiogenesis; 2012 Dec; 15(4):569-80. PubMed ID: 22644563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
    Erdmann S; Niederstadt L; Koziolek EJ; Gómez JDC; Prasad S; Wagener A; von Hacht JL; Reinicke S; Exner S; Bandholtz S; Beindorff N; Brenner W; Grötzinger C
    Theranostics; 2019; 9(22):6719-6733. PubMed ID: 31588246
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficient
    Veleva AN; Nepal DB; Frederick CB; Schwab J; Lockyer P; Yuan H; Lalush DS; Patterson C
    Molecules; 2011 Jan; 16(1):900-14. PubMed ID: 21258297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Preclinical Evaluation of a
    Li H; Yuan L; Long Y; Fang H; Li M; Liu Q; Xia X; Qin C; Zhang Y; Lan X; Gai Y
    Mol Pharm; 2020 Aug; 17(8):3000-3008. PubMed ID: 32544337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy.
    Morrison MS; Ricketts SA; Barnett J; Cuthbertson A; Tessier J; Wedge SR
    J Nucl Med; 2009 Jan; 50(1):116-22. PubMed ID: 19091899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel molecular imaging of atherosclerosis with gallium-68-labeled apolipoprotein A-I mimetic peptide and positron emission tomography.
    Kawachi E; Uehara Y; Hasegawa K; Yahiro E; Ando S; Wada Y; Yano T; Nishikawa H; Shiomi M; Miura S; Watanabe Y; Saku K
    Circ J; 2013; 77(6):1482-9. PubMed ID: 23459406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.
    Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabeled GX1 Peptide for Tumor Angiogenesis Imaging.
    de Oliveira ÉA; Faintuch BL; Seo D; Barbezan AB; Funari A; Targino RC; Moro AM
    Appl Biochem Biotechnol; 2018 Aug; 185(4):863-874. PubMed ID: 29362989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    López-Rodríguez V; Galindo-Sarco C; García-Pérez FO; Ferro-Flores G; Arrieta O; Ávila-Rodríguez MA
    J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5.
    Rossin R; Kohno T; Hagooly A; Sharp T; Gliniak B; Arroll T; Chen Q; Hewig A; Kaplan-Lefko P; Friberg G; Radinsky R; Evelhoch JL; Welch MJ; Hwang DR
    J Nucl Med; 2011 Jun; 52(6):942-9. PubMed ID: 21571804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
    Qi S; Hoppmann S; Xu Y; Cheng Z
    Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.